These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24573104)

  • 1. Brand loyalty, patients and limited generic medicines uptake.
    Costa-Font J; Rudisill C; Tan S
    Health Policy; 2014 Jun; 116(2-3):224-33. PubMed ID: 24573104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2015 Feb; 37(1):68-75. PubMed ID: 25428446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic medications for you, but brand-name medications for me.
    Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
    Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?
    Cameron A; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
    Value Health; 2012; 15(5):664-73. PubMed ID: 22867775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospective study of the factors associated with the acceptance of generics substitution by patients and their liberal doctors].
    Iskounen S; Simoneau G; Mouly S
    Rev Med Interne; 2018 Nov; 39(11):849-854. PubMed ID: 29290412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
    Kwong WJ; Kamat S; Fang C
    Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generics: keep a balanced view.
    Prescrire Int; 2014 Feb; 23(146):52-5. PubMed ID: 24669392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Three types of brand name loyalty strategies set up by drug manufacturers].
    PréMont MC; Gagnon MA
    Healthc Policy; 2014 Nov; 10(2):79-89. PubMed ID: 25617517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of generic substitution: The role of psychological, sociodemographic, and contextual factors.
    Drozdowska A; Hermanowski T
    Res Social Adm Pharm; 2016; 12(1):119-129. PubMed ID: 25935316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: the case of lamotrigine in New Zealand.
    Lessing C; Ashton T; Davis P
    Appl Health Econ Health Policy; 2014 Oct; 12(5):537-46. PubMed ID: 25005492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perception, knowledge, and use of generic drugs in southern Brazil: what changed from 2002 to 2012?].
    Guttier MC; Silveira MP; Luiza VL; Bertoldi AD
    Cad Saude Publica; 2016 Aug; 32(7):. PubMed ID: 27487440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution.
    Palagyi M; Lassanova M
    Bratisl Lek Listy; 2008; 109(7):324-8. PubMed ID: 18792489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.
    Hansen RA; Qian J; Berg R; Linneman J; Seoane-Vazquez E; Dutcher SK; Raofi S; Page CD; Peissig P
    Pharmacotherapy; 2017 Apr; 37(4):429-437. PubMed ID: 28152215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perceptions of generic drugs in Greece.
    Skaltsas LN; Vasileiou KZ
    Health Policy; 2015 Nov; 119(11):1406-14. PubMed ID: 26477667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic substitution of antiepileptic drugs--a survey of patients' perspectives in Germany and other German-speaking countries.
    Hensler K; Uhlmann C; Porschen T; Benecke R; Rösche J
    Epilepsy Behav; 2013 Apr; 27(1):135-9. PubMed ID: 23416284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines].
    Ringuier R; Rouquette A; Dagorne C; Garnier F; Fanello S
    Therapie; 2008; 63(1):11-7. PubMed ID: 18387271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.
    Saleh S; Abou Samra C; Jleilaty S; Constantin J; El Arnaout N; Dimassi H; Al-Bittar D
    Int J Clin Pharm; 2017 Oct; 39(5):1101-1109. PubMed ID: 28823020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic.
    Maly J; Dosedel M; Kubena A; Vlcek J
    Acta Pol Pharm; 2013; 70(5):923-31. PubMed ID: 24147373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.